Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruina Li

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's diseaseBoye Wen, Xiaodong Han, Jin Gong, et al.
Toxicology and Applied Pharmacology|July 15, 2023
Smarca2 genetic ablation is phenotypically benign in a safety assessment of tamoxifen-inducible conditional knockout ratsJonathan Maher, Nicola Stagg, Gary Cain, et al.
Journal of Medicinal Chemistry|November 21, 2017
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) InhibitorsSarah M Bronner, Jeremy Murray, F Anthony Romero, et al.
Chemmedchem|November 2, 2019
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo ActivityThomas H Pillow, Pragya Adhikari, Robert A Blake, et al.
Journal of Medicinal Chemistry|September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's diseaseBoye Wen, Xiaodong Han, Jin Gong, et al.
Toxicology and Applied Pharmacology|July 15, 2023
Smarca2 genetic ablation is phenotypically benign in a safety assessment of tamoxifen-inducible conditional knockout ratsJonathan Maher, Nicola Stagg, Gary Cain, et al.
Journal of Medicinal Chemistry|November 21, 2017
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) InhibitorsSarah M Bronner, Jeremy Murray, F Anthony Romero, et al.
Chemmedchem|November 2, 2019
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo ActivityThomas H Pillow, Pragya Adhikari, Robert A Blake, et al.
Journal of Medicinal Chemistry|September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.
Pageof 6